Galapagos NV
GLPG
#4961
Rank
NZ$3.19 B
Marketcap
NZ$47.52
Share price
0.00%
Change (1 day)
-0.22%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): NZ$0.96 Billion

According to Galapagos NV's latest financial reports the company's current earnings are NZ$1.22 Billion. In 2025 the company made an earning of NZ$0.63 Billion, an increase over its 2024 earnings that were of -NZ$9.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.96 B53.27%
2025 NZ$0.63 B-6464.81%
2024 -NZ$9.91 Million-82.77%
2023 -NZ$57.48 Million-85.59%
2022 -NZ$0.4 Billion60.71%
2021 -NZ$0.25 Billion-60.08%
2020 -NZ$0.63 Billion-331.44%
2019 NZ$0.26 B-523.76%
2018 -NZ$63.42 Million-72.34%
2017 -NZ$0.23 Billion-329.59%
2016 NZ$99.86 M-144.3%
2015 -NZ$0.23 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.52 B 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.94 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$11.30 B 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.12 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$22.53 B 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.12 B 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$17.15 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-NZ$91.64 Million-109.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.89 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel